U.S. Aerospace & Defense Stock News

NYSE:CSL
NYSE:CSLBuilding

Is Carlisle Companies (CSL) Offering Value After Recent Share Price Pullback?

For investors considering whether Carlisle Companies stock at around US$333.80 offers value or appears fully priced, this article reviews what the numbers indicate about the current share price. The stock is up 0.9% over the last week, down 5.6% over the past month, up 1.6% year to date, and the 1-year return is a decline of 12.6%. The 3-year and 5-year returns stand at 59.1% and 83.2% respectively. Recent coverage has focused on Carlisle Companies as a US industrial conglomerate with...
NasdaqGS:GRAB
NasdaqGS:GRABTransportation

What Grab Holdings (GRAB)'s Superbank Takeover Means For Shareholders

Earlier this month, Grab Holdings Limited said it will take majority control of Indonesian digital lender Superbank, fully consolidating its financials from May 2026 and bringing the fast-growing bank into Grab’s Financial Services segment. This move deepens Grab’s presence in Indonesia’s digital finance ecosystem and ties Superbank’s multi-million customer base more tightly into Grab’s wider superapp platform. We’ll now examine how majority control of Superbank could reshape Grab’s...
NYSE:NTB
NYSE:NTBBanks

Assessing Bank of N.T. Butterfield & Son (NTB) Valuation After Q1 Earnings And Guernsey Acquisition Completion

Q1 results and acquisition put Bank of N.T. Butterfield & Son (NTB) in focus Bank of N.T. Butterfield & Son (NTB) is back on investor radars after reporting strong first quarter earnings, highlighting firm profitability, disciplined cost controls, and the closing of its Rollinson & Hunter Guernsey acquisition. See our latest analysis for Bank of N.T. Butterfield & Son. Despite a slight 0.16% decline in the latest trading session to US$56.01, the stock has a 12.7% year to date share price...
NasdaqCM:TGTX
NasdaqCM:TGTXBiotechs

How Investors May Respond To TG Therapeutics (TGTX) Boosting 2026 Guidance On Stronger Briumvi Sales

TG Therapeutics recently raised its total revenue guidance for 2026 after reporting stronger-than-expected sales of Briumvi, its approved therapy for relapsing forms of multiple sclerosis. The company is also running multiple clinical studies aimed at broadening Briumvi’s indications and improving how it is administered, which could reshape its longer-term product profile. We’ll now examine how the upgraded 2026 revenue guidance tied to Briumvi’s performance could influence TG Therapeutics’...
NYSE:EL
NYSE:ELPersonal Products

Estée Lauder Ends Puig Talks And Refines Beauty Reimagined Turnaround Focus

Estée Lauder Companies (NYSE:EL) has ended merger talks with Spanish beauty group Puig, according to recent company communications. Management is refocusing on the "Beauty Reimagined" turnaround plan and reviewing its brand portfolio at the same time. Discussions around potential divestitures reportedly include brands such as Too Faced, Smashbox, and Dr. Jart. For you as an investor, the key point is that NYSE:EL is doubling down on its core turnaround efforts rather than pursuing large...
NYSE:FRO
NYSE:FROOil and Gas

Frontline (NYSE:FRO) Q1 Net Margin Strength Challenges Bearish Earnings Narratives

Frontline (NYSE:FRO) has come out of Q1 2026 with revenue of US$714.2 million and basic EPS of US$2.51, against a backdrop of strong trailing 12 month EPS of US$4.06 on revenue of US$2.3 billion. Over the past year, the company has seen quarterly revenue move from US$427.9 million in Q1 2025 to US$714.2 million in Q1 2026, while basic EPS shifted from US$0.15 to US$2.51. This sets up a results season where investors are likely to focus on how much of this earnings strength can be sustained...
NYSE:CLF
NYSE:CLFMetals and Mining

Cleveland Cliffs (CLF) Valuation Check After Earnings Beat And Reaffirmed 2026 Outlook

Cleveland-Cliffs (CLF) is back on investors’ radar after reporting a narrower first quarter adjusted loss than expected, beating revenue estimates and reaffirming its full year 2026 outlook for steel shipments and capital spending. See our latest analysis for Cleveland-Cliffs. The latest earnings surprise and reaffirmed 2026 guidance have coincided with a sharp move in the stock, with a 30 day share price return of 18.21%. This comes even though the year to date share price return is still...
NYSE:MTDR
NYSE:MTDROil and Gas

A Look At Matador Resources (MTDR) Valuation After Recent Share Price Cooling

Matador Resources (MTDR) has been drawing attention after recent share price swings, with the stock up about 31% year to date but down around 6% over the past month. See our latest analysis for Matador Resources. Recent share price returns show some cooling in the short term, with a 7 day share price return of down 6.13% and a 30 day share price return of down 6.23%. This is despite a year to date share price return of 30.63% and a 1 year total shareholder return of 34.55%. If Matador...
NYSE:SPCE
NYSE:SPCEAerospace & Defense

A Look At Virgin Galactic (SPCE) Valuation As Funding Risks And Test Milestones Draw New Scrutiny

Virgin Galactic Holdings (SPCE) is back in focus after first quarter 2026 results showed continued losses, a new US$40.2 million shelf registration filing, and ongoing questions around cash burn, funding options, and upcoming test milestones. See our latest analysis for Virgin Galactic Holdings. The recent 17.82% 1 day share price return and 31.71% 90 day share price return show short term momentum building around Virgin Galactic, even as the 1 year total shareholder return declined 12.90%...
NasdaqGS:FRSH
NasdaqGS:FRSHSoftware

Freshworks (FRSH) Valuation Check As AI Service Transformation Vision Gains Traction

Freshworks' AI service push and why it matters for FRSH stock Freshworks (FRSH) recently outlined its Service Transformation, Made Real vision, highlighting an expanded Freddy AI Agent Studio and ecosystem that promise faster deployment of AI driven service workflows across IT, HR, and other internal support functions. The launch leans on telemetry from millions of service interactions. This includes the finding that 47% of IT tickets now arrive outside standard hours, while after hours...
NasdaqGS:EA
NasdaqGS:EAEntertainment

A Look At Electronic Arts (EA) Valuation After A Strong 1 Year Shareholder Return

Recent share performance context Electronic Arts (EA) shares recently closed at US$200.97. The stock has been roughly flat over the past week and slightly down over the past month, while still showing a gain over the past three months. See our latest analysis for Electronic Arts. Short term share price moves have been muted, with limited momentum over the past quarter. However, the 1 year total shareholder return of 37.40% points to a stronger longer term trend supported by price gains and...
NasdaqGS:DLO
NasdaqGS:DLODiversified Financial

Assessing DLocal (DLO) Valuation After Strong Q1 2026 Growth And Maintained Guidance

Why Q1 2026 is in Focus for DLocal (DLO) DLocal (DLO) is back on investor radar after reporting Q1 2026 results that paired Total Payment Volume and revenue growth with maintained full year guidance, despite a one off tax adjustment. Total Payment Volume moved past US$14b for the quarter, with revenue of US$335.9 million, supported by what management described as base business momentum in emerging markets and secular growth trends across its key geographies. See our latest analysis for...
NYSE:HUBS
NYSE:HUBSSoftware

How Investors Are Reacting To HubSpot (HUBS) AI Pricing Reset And Evolving Growth Narrative

In recent weeks, HubSpot has reported strong Q1 revenue growth, updated its AI pricing model, announced CEO Yamini Rangan’s upcoming Evercore TMT Global Conference appearance, and disclosed an insider share sale by director Brian Halligan under a pre-arranged trading plan. Together, these developments highlight how HubSpot is balancing AI-driven product evolution and upmarket expansion with investor concerns about pricing changes, growth durability, and the long-term impact of generative AI...
NYSE:CDRE
NYSE:CDREAerospace & Defense

Is It Time To Reconsider Cadre Holdings (CDRE) After This Year’s Share Price Slide

Wondering if Cadre Holdings at about US$30.31 is starting to look interesting, or if the stock still does not stack up on value? This article walks through what current pricing might be telling you. The stock has inched up around 1.8% over the past week and 2.4% over the past month, yet it remains down about 26.3% year to date and 6.3% over the past year, while still showing a 48.2% gain over three years. Recent coverage has focused on how Cadre Holdings is positioned within the broader...
NYSE:VZ
NYSE:VZTelecom

Verizon Joins Project Glasswing As AI Security Meets Valuation Debate

Verizon Communications (NYSE:VZ) has joined Project Glasswing, a new initiative focused on protecting critical infrastructure in the AI era. The company is partnering with Anthropic to apply and test advanced AI models under strict internal cybersecurity and safety protocols. The effort centers on securing telecommunications networks and other essential systems as AI tools become more deeply integrated into operations. For investors following NYSE:VZ, this move sits at the intersection of...
NYSE:MKL
NYSE:MKLInsurance

Markel Expands Specialty Risk Focus With Nuclear Facility And London Hire

Markel Group (NYSE:MKL) has launched its first dedicated nuclear insurance facility in partnership with Willis. The new facility targets risks linked to global nuclear energy projects and growing power needs from data centers and AI. Markel has also appointed Danny O'Donoghue as Head of Fine Art & Specie for its London operations. Markel Group, trading at $1,857.89, is moving further into complex specialty lines with these announcements. The stock is down 12.8% year to date and down 4.4%...
NYSE:GD
NYSE:GDAerospace & Defense

A Look At General Dynamics (GD) Valuation After Recent Share Price Momentum

What recent performance suggests about General Dynamics (GD) Without a specific news headline driving attention today, General Dynamics (GD) is drawing interest after recent trading results, including a last close of US$342.89 and varied short and longer term returns. See our latest analysis for General Dynamics. Recent trading has lifted General Dynamics' 1 month share price return to 6.91% even as the 3 month share price return is down 2.43%. At the same time, the 1 year total shareholder...
NasdaqGS:SOFI
NasdaqGS:SOFIConsumer Finance

Record Q1 Results And Stablecoin Push Could Be A Game Changer For SoFi Technologies (SOFI)

In May 2026, SoFi Technologies reported record first-quarter results, including strong year-over-year growth in adjusted net revenue and net income, robust loan originations, and continued expansion in members and products, while management reaffirmed full-year guidance and advanced initiatives such as its newly minted stablecoin with Mastercard. At the same time, SoFi’s ambition to become a top-10 US bank is being tested by pressure on its Technology Platform segment, mixed analyst views,...
NasdaqGS:PSKY
NasdaqGS:PSKYMedia

Paramount Skydance Deal Faces Foreign Ownership Questions And Debt Reset

Paramount Skydance (NasdaqGS:PSKY) and Warner Bros. Discovery are facing new regulatory scrutiny as U.S. senators urge the FCC to examine foreign ownership links in their pending deal. Lawmakers are raising national security and editorial independence concerns tied to Middle Eastern and Chinese investors involved with Paramount Skydance. Alongside this, Paramount Skydance is pursuing large debt financing and new leadership hires to push into AI, adding another layer of change around the...
NasdaqGS:RVMD
NasdaqGS:RVMDBiotechs

What Revolution Medicines (RVMD)'s Phase 3 Daraxonrasib Survival Data Means For Shareholders

Revolution Medicines recently reported positive Phase 3 RASolute 302 results for its RAS(ON) inhibitor daraxonrasib in previously treated metastatic pancreatic ductal adenocarcinoma, with data featured in the Plenary Session at the 2026 ASCO Annual Meeting and supported by a company webcast and NEJM publication. The company also highlighted that daraxonrasib delivered what it described as unprecedented overall survival benefit, reinforcing the potential importance of RAS-targeted therapies...
NYSE:UTI
NYSE:UTIConsumer Services

Is S&P SmallCap 600 Inclusion Reshaping the Investment Case for Universal Technical Institute (UTI)?

Universal Technical Institute recently announced it will join the S&P SmallCap 600 index, replacing Veris Residential following that company’s acquisition by Affinius Capital and Vista Hill Partners. This index inclusion, arriving amid sector-wide pressure on consumer discretionary names, brings fresh attention from institutional investors to a business already wrestling with underperforming new student trends and weaker returns on capital. We’ll now explore how UTI’s upcoming S&P SmallCap...
NYSE:MPLX
NYSE:MPLXOil and Gas

Assessing MPLX (MPLX) Valuation After Fresh Income‑Focused Analyst Commentary

Income appeal and fresh analyst commentary put MPLX (MPLX) in focus Recent commentary around MPLX (MPLX) highlights its near 8% yield, guided double digit distribution growth through 2027, and lower risk profile, drawing fresh attention from income focused investors. See our latest analysis for MPLX. The stock’s recent 1 day share price return of 1.53% and 7 day return of 3.10% come after a period where the 90 day share price return declined 2.96%, while the 1 year total shareholder return of...
NYSE:NIO
NYSE:NIOAuto

NIO (NIO) Is Down 14.8% After Profitability Milestones And Premium Mix Shift - Has The Bull Case Changed?

NIO Inc. has reported its first quarter 2026 results, with revenue rising to CNY 25,532.66 million, net loss narrowing to CNY 496.01 million, and guidance for second quarter 2026 pointing to revenues of roughly US$4.75 billion–US$4.99 billion on 110,000–115,000 vehicle deliveries. Beyond the headline growth, the company’s second consecutive quarter of adjusted profitability, higher-margin ES8 mix, and the launch of the flagship ES9 and ONVO L80 suggest a business increasingly focused on...
NYSE:ELF
NYSE:ELFPersonal Products

A Look At e.l.f. Beauty’s (ELF) Valuation After A Sharp Multi‑Month Share Price Pullback

Recent share performance context e.l.f. Beauty (ELF) has come under pressure recently, with the stock down about 19% over the past month and roughly 44% over the past 3 months, prompting investors to reassess current valuations. See our latest analysis for e.l.f. Beauty. Looking beyond the recent pullback, e.l.f. Beauty’s share price has softened this year, with the year to date share price return down 32.01%, while the 5 year total shareholder return of 88.93% still reflects a much stronger...